SLC38A4 Functions as a Tumour Suppressor in Hepatocellular Carcinoma through Modulating Wnt/β-Catenin/MYC/HMGCS2 Axis

0
26
Researchers identified a common molecular event which would provide a novel prognostic biomarker and therapeutic target for hepatocellular carcinoma.
[British Journal of Cancer]

Sorry, but the selected Zotpress account can't be found.

Abstract